Focused on novel, nanotechnology-based therapeutics

Oliver Fetzer, Ph.D.
President and Chief Executive Officer

David P. DeMagistris, Ph.D.
Senior Vice President, Pharmaceutical Sciences and Manufacturing

Scott Eliasof, Ph.D.
Senior Director, Research

Alexandra Glucksmann, Ph.D.
Senior Vice President, Research and Business Operations

Karen Roberts
Senior Vice President, Finance and Administration

John Ryan, Ph.D., M.D.
Senior Vice President and Chief Medical Officer

Jean Silveri, J.D.
Senior Vice President, General Counsel

Marc Wolfgang
Senior Director, Pharmaceutical Sciences and Manufacturing

Cissy Young, Ph.D.
Director, Strategy and Business Development

Prior to joining Cerulean, Cissy was Director of Business Development at TetraLogic Pharmaceuticals in Malvern, PA, a privately held oncology therapeutics company. As one of the early employees of TetraLogic, she spearheaded business development and licensing, market development, and research collaboration management. She also worked closely with the executive team and supported key strategic events including financing and collaboration partnership implementation. Cissy was previously Technology Licensing Officer for Pennsylvania State University Technology Transfer, where she was responsible for licensing and managed the life sciences technology portfolio.

Cissy received her B.A. from Brown University in biology, Ph.D. from Columbia University in Cancer Biology, and an MBA from Pennsylvania State University.